News
Novartis taps China's Abogen for autoimmunity TCE
Novartis has added a T-cell engager developed by China's Abogen Biosciences for autoimmune disorders in a deal that could be worth over $7.5bn.
R&D
Alzheimer’s: Starting the impossible journey
Not long ago, the prospect of having disease-modifying treatments for Alzheimer’s disease (AD) seemed almost a flight of fancy.
News
New diabetes and obesity studies making waves at EASD
As the EASD congress draws to a close, here's a round-up of some of the other clinical trials in diabetes and obesity that drew our attention.
News
Space pharma Varda raises $251m, and other financings
Varda has closed a $251m round to fuel its mission to make medicines in orbit, with TriGemX, Breye, AnaCardio, and ai3Bio also raising new funds.
R&D
Bioconvergence & future human health, with Shai Melcer
Shai Melcer discusses bioconvergence, a multidisciplinary research and development approach that merges technologies.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
